BSE Live
Apr 06, 16:01Prev. Close
333.35
Open Price
328.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 06, 15:52Prev. Close
333.25
Open Price
331.20
Bid Price (Qty.)
336.90 (1086)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of FDC (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 16.81 | 18.70 | 12.09 | 13.01 | 17.32 | |
| Diluted EPS (Rs.) | 16.81 | 18.70 | 12.09 | 13.01 | 17.32 | |
| Cash EPS (Rs.) | 20.10 | 21.31 | 14.45 | 15.21 | 19.67 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 140.48 | 128.81 | 119.39 | 115.44 | 102.02 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 140.48 | 128.81 | 119.39 | 115.44 | 102.02 | |
| Dividend / Share(Rs.) | 5.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 127.15 | 117.69 | 107.11 | 89.98 | 78.52 | |
| PBDIT/Share (Rs.) | 26.15 | 27.13 | 18.59 | 19.29 | 24.97 | |
| PBIT/Share (Rs.) | 22.86 | 24.69 | 16.26 | 17.09 | 22.74 | |
| PBT/Share (Rs.) | 22.58 | 24.44 | 16.01 | 16.91 | 22.54 | |
| Net Profit/Share (Rs.) | 16.81 | 18.87 | 12.11 | 13.01 | 17.45 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 20.56 | 23.04 | 17.35 | 21.43 | 31.79 | |
| PBIT Margin (%) | 17.97 | 20.97 | 15.17 | 18.99 | 28.96 | |
| PBT Margin (%) | 17.76 | 20.76 | 14.95 | 18.79 | 28.70 | |
| Net Profit Margin (%) | 13.21 | 16.02 | 11.30 | 14.45 | 22.21 | |
| Return on Networth / Equity (%) | 11.96 | 14.64 | 10.14 | 11.27 | 17.09 | |
| Return on Capital Employed (%) | 15.80 | 18.68 | 13.32 | 14.54 | 22.04 | |
| Return on Assets (%) | 10.09 | 12.49 | 8.60 | 9.74 | 15.15 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 0.80 | 0.80 | 0.77 | 0.72 | 0.71 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.01 | 3.43 | 3.30 | 3.65 | 4.57 | |
| Quick Ratio (X) | 1.97 | 2.18 | 2.25 | 2.53 | 3.52 | |
| Inventory Turnover Ratio (X) | 5.51 | 1.65 | 1.87 | 1.75 | 1.64 | |
| Dividend Payout Ratio (NP) (%) | 29.75 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 24.87 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 70.25 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 75.13 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 6,378.62 | 6,890.48 | 4,235.73 | 4,304.88 | 4,796.38 | |
| EV/Net Operating Revenue (X) | 3.08 | 3.60 | 2.38 | 2.83 | 3.62 | |
| EV/EBITDA (X) | 14.98 | 15.60 | 13.73 | 13.22 | 11.38 | |
| MarketCap/Net Operating Revenue (X) | 3.10 | 3.61 | 2.40 | 2.86 | 3.64 | |
| Retention Ratios (%) | 70.24 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 2.81 | 3.30 | 2.15 | 2.23 | 2.80 | |
| Price/Net Operating Revenue | 3.10 | 3.61 | 2.40 | 2.86 | 3.64 | |
| Earnings Yield | 0.04 | 0.04 | 0.05 | 0.05 | 0.06 |
10.02.2026
FDC Consolidated December 2025 Net Sales at Rs 464.71 crore, up 0.13% Y-o-Y
09.02.2026
FDC Standalone December 2025 Net Sales at Rs 457.94 crore, down 0.2% Y-o-Y
11.11.2025
FDC Standalone September 2025 Net Sales at Rs 461.74 crore, down 8.58% Y-o-Y
07.11.2025
FDC Consolidated September 2025 Net Sales at Rs 473.03 crore, down 7.94% Y-o-Y
10.02.2026
FDC Consolidated December 2025 Net Sales at Rs 464.71 crore, up 0.13% Y-o-Y
09.02.2026
FDC Standalone December 2025 Net Sales at Rs 457.94 crore, down 0.2% Y-o-Y
11.11.2025
FDC Standalone September 2025 Net Sales at Rs 461.74 crore, down 8.58% Y-o-Y
07.11.2025
FDC Consolidated September 2025 Net Sales at Rs 473.03 crore, down 7.94% Y-o-Y
06.04.2026
06.04.2026
02.04.2026
02.04.2026
Lupin shares down 2% as arm to acquire 43.38% stake in Multicare Pharma
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth